In recent years, the pervasive presence of per- and polyfluoroalkyl substances (PFAS) in water has become a focal point for environmental engineers, public health advocates, and regulatory agencies alike. These man-made chemicals, often dubbed “forever chemicals” due to their persistence in the environment, pose substantial health risks and environmental challenges. This article aims to provide an in-depth analysis of PFAS in water, examining its implications, regulatory landscape, and innovative treatment solutions as of July 30, 2025.
Occurrence is where every PFAS program begins, and it is also where most of the confusion lives. A detection is not a violation, a non-detect is not an assurance, and the water a household actually drinks may or may not be covered by any enforceable standard at all depending on whether it comes from a utility or a private well. Alongside the broader subject of PFAS removal in wastewater treatment, this page serves as the category hub for PFAS occurrence in water: where these compounds are found and how they get there, what the monitoring data does and does not tell you, which water systems are regulated and which are not, and what a detection actually obliges a utility or a well owner to do.
PFAS comprise a wide range of synthetic chemicals including PFOA, PFOS, and GenX. They are commonly used in various industries for their water- and grease-repellent properties. Found in items like non-stick cookware, waterproof clothing, food packaging, and firefighting foams, PFAS have entered water sources through industrial discharge, landfill leachate, and agricultural runoff.
Research has linked PFAS exposure to serious health issues, including:
As of 2024, industry analysis indicated that an estimated 50% of U.S. drinking water sources contain detectable levels of PFAS, with concentrations varying significantly across regions.
Percentages of this kind circulate widely and are worth handling carefully, because they are almost entirely a function of the reporting limit applied. A study using a very low analytical reporting limit will find PFAS in a large share of samples; the same water tested against a higher limit will show far fewer detections. Neither result is wrong, and neither on its own tells you whether treatment is required.
Two U.S. datasets carry the most weight. EPA’s fifth Unregulated Contaminant Monitoring Rule required nationwide sampling of large public water systems and a representative set of smaller ones, using specified methods and minimum reporting levels, and is the authoritative basis for regulated-system occurrence. A U.S. Geological Survey tap water study published in 2023 sampled both public supply and private wells and reported PFAS in a substantial fraction of samples nationwide. When citing any occurrence figure, name the dataset, the reporting limit, and the compound list — a “50 percent” figure means something quite different at a 2 part-per-trillion reporting limit than at a 20 part-per-trillion one.
In 2023, the U.S. Environmental Protection Agency (EPA) issued new health advisories for PFOA and PFOS, recommending action levels of 0.004 parts per trillion (ppt) and 0.02 ppt, respectively. By 2025, the proposed PFAS Action Act aims to regulate all PFAS in drinking water, mandating states to establish enforceable standards.
Two clarifications belong alongside that description, because the regulatory picture has moved and the distinction between the instruments matters.
The interim health advisories referenced above were issued in June 2022, not 2023, and — more importantly — health advisories are non-enforceable guidance rather than regulation. They were superseded in April 2024 when EPA finalized a National Primary Drinking Water Regulation establishing enforceable maximum contaminant levels: 4.0 parts per trillion each for PFOA and PFOS, 10 parts per trillion each for PFHxS, PFNA, and HFPO-DA (GenX chemicals), and a Hazard Index approach for mixtures including PFBS. A public water system exceeding an MCL has a violation with defined consequences; a system exceeding a health advisory did not. That is the difference between the two regimes.
On the legislative point, the PFAS Action Act passed the House of Representatives in 2021 but was not enacted into law, and it is not the mechanism through which PFAS drinking water limits took effect. The federal limits arose under existing Safe Drinking Water Act authority through the 2024 rule. Many states, meanwhile, adopted their own PFAS drinking water standards ahead of the federal rule and in some cases set them lower or across a wider compound list, and those state PFAS regulations continue to operate alongside the federal MCLs — a system must meet whichever is more stringent. Because the federal rule has been subject to litigation and to subsequent reconsideration affecting compliance timing and some individual compounds, verify current requirements with EPA and the state primacy agency before relying on any of this for planning.
The reach of the drinking water regulation is narrower than most readers assume, and it is the single most useful thing to understand about PFAS occurrence. The Safe Drinking Water Act applies to public water systems, and within that category the rules distinguish community water systems serving year-round residents from non-transient non-community systems such as schools and workplaces and from transient systems such as campgrounds. Monitoring and MCL compliance obligations differ across those categories.
Private domestic wells fall outside the framework entirely. Roughly forty million Americans draw their household water from a private well, and for those households there is no required monitoring, no MCL, no notification, and no treatment obligation — testing is voluntary and self-funded. Since private wells are common precisely in the rural areas near airfields, military installations, landfills, and land-applied biosolids where PFAS contamination concentrates, the population with the least regulatory protection frequently overlaps with the population at greatest risk of exposure.
Countries like the EU are at the forefront, having classified PFAS as hazardous substances under the REACH regulations, setting stringent limits on their use. As a result, many manufacturers are pivoting to safer alternatives.
To be precise about the European position: individual compounds including PFOA and PFOS are restricted under the EU’s Persistent Organic Pollutants Regulation rather than being classified wholesale under REACH, and a proposal for a universal PFAS restriction covering the class as a whole was submitted under REACH in 2023 and remains under evaluation. Separately, the EU Drinking Water Directive sets parametric values for PFAS in drinking water. The direction of travel is as the passage above describes; the mechanism is several distinct instruments rather than one.
PFAS contaminants primarily enter water systems from:
Two further pathways deserve naming because they account for a large share of municipal detections. Landfill leachate concentrates PFAS from decades of consumer products and is commonly discharged to a wastewater treatment plant that was never designed to remove it, which then passes it to the receiving water. And land application of biosolids distributes PFAS onto agricultural soil, from which it can migrate to groundwater and surface water over time. Both routes mean a community with no PFAS manufacturing anywhere near it can still show detections.
PFAS are resistant to degradation due to their strong carbon-fluorine bonds. Consequently, standard wastewater treatment methods are often ineffective in removing these substances, necessitating specialized treatment technologies.
Persistence explains why PFAS remains, but transport explains where it ends up, and the two behave differently across water types. In groundwater, PFAS forms long, slow plumes that can extend for miles from a source and persist for decades, with short-chain compounds travelling fastest because they sorb least to soil. That mobility means the leading edge of a plume is typically enriched in the short-chain compounds that adsorptive treatment handles least well — the harder problem arrives first.
In surface water, dilution reduces concentrations but does not remove the compounds, and levels vary with flow, so a river source may test clean at high flow and exceed a limit during a drought. Precursor transformation adds a further complication: many PFAS in the environment are partially fluorinated compounds that degrade over time into the terminal perfluoroalkyl acids that regulations target, so a site’s measured PFOA and PFOS can increase over years without any new release. For a utility, the practical consequence is that a single clean sample is weak evidence — occurrence in a source needs to be characterized across seasons and flow conditions before it can be relied on.
Five subject areas sit beneath this category, organized by the kind of water system involved — from the drinking water supply generally, through the regulatory categories of public and community systems, to unregulated private wells and the solutions available to utilities.
The treated supply that reaches a tap is covered in depth under PFAS in drinking water, addressing occurrence in finished water specifically, how the federal MCLs and state standards apply to it, the monitoring schedule a system must follow, and the public notification obligations that attach to an exceedance. This is also where the distinction between raw source water and finished water matters most: conventional treatment does not remove PFAS, so finished water concentrations generally track source water concentrations unless dedicated treatment has been installed. Consumer confidence reporting, health risk communication, and the practical question of what a utility tells its customers when a detection occurs all belong to this area.
The regulatory unit that PFAS obligations actually attach to is the public water system, and public water system PFAS covers how the requirements differ across the categories the Safe Drinking Water Act defines — community systems, non-transient non-community systems such as schools, workplaces, and hospitals, and transient non-community systems such as campgrounds and highway rest areas. Monitoring frequency, compliance calculation, and notification requirements are not uniform across those categories, and small systems face compliance schedules and funding realities quite different from large ones. Understanding which category a system falls into is the first step in determining what it actually has to do.
Within that framework, community water system PFAS addresses the systems serving year-round residential populations, which carry the fullest set of obligations and the greatest public visibility. These are the systems subject to consumer confidence reporting, to the most demanding monitoring schedules, and to the political and rate-setting pressures that follow a detection becoming public. The area covers compliance planning, capital funding pathways including state revolving funds and the federal programs directed at emerging contaminants, interim measures such as blending or source switching while permanent treatment is designed, and the customer communication that a residential service population requires.
Outside the regulatory framework entirely, PFAS in well water covers private domestic wells, where no monitoring is required, no standard applies, and the household bears the full cost of testing and treatment. Practical guidance in this area covers how to obtain a valid sample, which laboratory method to request, how to interpret a result against the federal MCLs even though they do not legally apply, and what point-of-entry and point-of-use treatment options exist at household scale. Proximity to known source areas — airfields, fire training grounds, landfills, and fields receiving biosolids — is the strongest indicator of whether testing is worthwhile, and this is the population most likely to be exposed without knowing it.
Turning a detection into a response is covered under water utility PFAS solutions, spanning the full sequence a utility works through: confirming the result, characterizing the source and its variability, evaluating non-treatment options such as source switching, blending, or wellfield management, and then selecting, funding, and procuring treatment where those options are insufficient. Non-treatment options deserve serious evaluation before capital is committed — a utility with multiple sources may be able to manage a detection through operational changes at a fraction of the cost of a treatment plant, though blending strategies must be assessed against how the compliance calculation is performed.
The method depends on the matrix and the results are not interchangeable. EPA Methods 537.1 and 533 apply to drinking water and cover different, partially overlapping compound lists — 533 extends further into short-chain compounds. EPA Method 1633 covers wastewater, biosolids, soil, sediment, and tissue. Requesting the wrong method for the matrix produces data that cannot be used for the purpose it was collected for, and this is a common and expensive project error.
PFAS sampling is unusually vulnerable to contamination introduced by the sampling itself, because the compounds are present in a wide range of everyday materials. Certain plastics and tubing, water-resistant field clothing, adhesive notes, and some personal care products worn by sampling staff have all been implicated in false positives. Laboratories supply specific containers and field protocols for this reason, and field and equipment blanks are not optional extras. A false positive from technique is indistinguishable in the data from real occurrence, and it can trigger notification, public alarm, and capital planning on the strength of a sampling error.
Two practical points close this out. First, a non-detect is only as meaningful as the reporting limit behind it: a result reported as non-detect at a limit of 4 parts per trillion tells you very little about compliance with a 4.0 part-per-trillion MCL, whereas the same non-detect at a 2 part-per-trillion limit is considerably more informative. Always read the reporting limit alongside the result.
Second, the concentrations involved are difficult to intuit. A 4 part-per-trillion limit is 4 nanograms per litre. In a million gallons of water — roughly 3.79 million litres — the entire regulated mass at that concentration is about 15 milligrams, less than the weight of a grain of rice. Treatment systems in this field are built to capture quantities of that order out of volumes of that order, which is why background organic matter competing for adsorption sites matters so much and why analytical rigour is not a formality.
Addressing PFAS contamination in water requires an adaptive approach. Here, we explore several effective treatment technologies. The technology landscape is covered in far greater depth under PFAS removal; what follows is the orientation an occurrence-focused reader needs.
Granular Activated Carbon (GAC) is widely used for PFAS treatment. By adsorbing contaminants onto its surface, GAC can effectively reduce PFAS levels. Recent advancements have seen the development of tailored GAC adsorbents specifically engineered to target PFAS compounds.
Pros:
Cons:
The efficiency claim needs a chain-length qualifier. GAC performs strongly against long-chain compounds such as PFOA and PFOS and considerably less well against short-chain compounds such as PFBA and PFBS, which break through much earlier. Since short-chain compounds increasingly dominate detections, a system validated only against the long-chain compounds will typically need media changed more often than expected.
Ion exchange resins selectively remove PFAS from water. These resins allow PFAS ions to swap with harmless ions, providing an effective treatment solution at lower concentrations.
Pros:
Cons:
On the regeneration point: most PFAS-selective ion exchange resins in municipal drinking water service are used on a single-use basis and are removed and disposed of rather than regenerated. Regenerable resins do exist, but regeneration produces a PFAS-laden brine that itself requires treatment or disposal, which is why single-use is the prevailing municipal practice. Resin disposal cost, not regeneration labour, is the operating burden to plan for.
Advanced Oxidation Processes (AOP) involve the generation of highly reactive hydroxyl radicals to degrade PFAS. This technology is especially beneficial for treating complex mixtures of PFAS.
Pros:
Cons:
The description above requires substantial qualification, and this is the most consequential technical point on the page. Conventional advanced oxidation processes — ozone with hydrogen peroxide, ultraviolet light with hydrogen peroxide, and related hydroxyl radical systems — are highly effective against most organic contaminants and are largely ineffective against fully fluorinated PFAS. The hydroxyl radical does not appreciably attack the carbon-fluorine bond, so PFOA and PFOS pass through conventional AOP substantially unchanged. Neither “breaking down even the most persistent PFAS” nor “complete mineralization” describes what hydroxyl radical chemistry does to a perfluoroalkyl acid.
There is a further complication that runs in the wrong direction. Oxidation converts partially fluorinated precursors into terminal perfluoroalkyl acids, which means an AOP step can raise measured PFOA and PFOS concentrations rather than lower them. A utility that installs conventional AOP expecting PFAS destruction may find its numbers move the wrong way.
Technologies that genuinely break the carbon-fluorine bond work through different mechanisms entirely — direct electron transfer at electrode surfaces in electrochemical oxidation, supercritical conditions in supercritical water oxidation, reductive defluorination in UV-sulfite systems, plasma, and hydrothermal alkaline treatment. They are real, but they are distinct from conventional AOP, are generally applied to small concentrated volumes rather than to full plant flow, and are less commercially mature than the separation technologies.
One framing point ties the three technologies above together. GAC, ion exchange, and membrane processes all separate PFAS from the water rather than destroying it: the treated water meets its limit and the utility inherits a spent medium or a concentrate carrying the contaminant. Disposal of that residual is an active regulatory and cost question, and it should be resolved during technology selection rather than after commissioning. A treatment decision made without a confirmed residuals route has relocated the liability rather than retired it.
| System Type | Federal PFAS MCLs Apply | Monitoring Required | Public Notification | Who Pays for Treatment |
|---|---|---|---|---|
| Community water system | Yes | Yes, on a defined schedule | Yes, including consumer confidence reporting | Ratepayers, with state and federal funding available |
| Non-transient non-community (schools, workplaces) | Yes | Yes | Yes | The facility owner |
| Transient non-community (campgrounds, rest areas) | Varies by contaminant and category | Limited | Limited | The facility owner |
| Private domestic well | No | None — testing is voluntary | None | The household, entirely |
| Water Type | Typical Concentration Pattern | Variability | Dominant Transport Behaviour | Monitoring Implication |
|---|---|---|---|---|
| Groundwater | Higher and more persistent near a source | Low over short periods; changes over years | Long slow plumes; short-chain compounds travel fastest | Plume leading edge is short-chain enriched |
| Surface water | Lower through dilution | High; varies with flow and season | Dilution and downstream transport, not removal | Sample across flow conditions, including drought |
| Wastewater effluent | Reflects the sewershed; leachate is a major input | Moderate | Passes through conventional treatment largely intact | Influent and effluent both needed to see pass-through |
| Finished drinking water | Tracks source water unless PFAS treatment is installed | Follows source variability | Conventional treatment does not remove PFAS | Do not assume treatment reduces it |
Resample using the correct method for the matrix, with field and equipment blanks, before treating a single result as real. Sampling-induced contamination is common enough that confirmation is standard practice, and a confirmation round costs a fraction of what a premature public notification does.
Obtain a full compound-level result including short-chain compounds, not just the regulated list, and sample across seasons and flow conditions. A source that exceeds a limit only during drought is a different problem from one that exceeds it continuously, and the chain-length distribution determines which treatment technologies will work.
Identify likely contributors — fire training areas, airfields, industrial dischargers, landfills, biosolids application areas — since source control is the only intervention that reduces the problem rather than managing it. In some cases a source can be addressed through pretreatment requirements on an industrial discharger at far lower cost than treating the whole supply.
Consider source switching, wellfield management, blending, and interconnection with a neighbouring system before committing capital. Blending in particular must be evaluated against how the compliance calculation is performed, but for a utility with multiple sources these options can resolve a detection at a small fraction of the cost of a treatment facility.
Where treatment is required, establish where the spent media or concentrate will go before selecting the technology, and pilot on the actual source water rather than relying on published performance figures from a different one.
Customers will hear about a detection regardless of whether the utility raises it. Explaining what was found, what the limit is, what the system is doing, and on what timeline is far more effective delivered proactively than in response to a news story, and it protects the rate support that funding a treatment project will require.
City of X Water District (2024): Implemented GAC and achieved a 99% reduction in PFOA levels, as documented in a comprehensive field study.
Green River Treatment Facility: The use of ion exchange resins successfully reduced PFOS levels below detection limits within three months.
Brief the sampling crew specifically on PFAS protocol rather than assuming general sampling competence transfers. Confirm the laboratory’s reporting limits in advance and check them against the MCLs the results will be compared to. Where treatment is installed, sample the lead vessel effluent as well as the final effluent, since a lead-lag arrangement keeps the final effluent compliant until breakthrough is nearly an exceedance. Retain sample records rigorously — PFAS data has a way of becoming evidence in a proceeding years later.
The recurring errors are treating a single sample as characterization, comparing results to a limit without reading the reporting limit, requesting a drinking water method for a wastewater or biosolids matrix, testing only the regulated compound list and missing a short-chain problem, assuming conventional treatment reduces PFAS, and notifying the public on an unconfirmed result. A quieter error is failing to sample during drought or low-flow conditions on a surface water source, which is exactly when concentrations peak.
Large systems generally have the sampling infrastructure, laboratory relationships, and engineering staff to work through occurrence characterization systematically. Small community systems frequently have none of these and face the same MCLs on a smaller rate base, which is what state assistance programs and regional consolidation efforts exist to address. Private well owners have no framework at all and rely on voluntary testing, which is why proximity-based outreach around known source areas is the most effective public health intervention available for that population.
Always read the laboratory reporting limit next to the result. A “non-detect” reported at a limit of 4 parts per trillion tells you almost nothing about compliance with a 4.0 part-per-trillion MCL, because the true value could sit just below the limit. Specify the required reporting limits when you commission the analysis, not after the results arrive, and make sure they leave real headroom below every standard the data will be compared against. Data that cannot demonstrate compliance is data you will have to pay to collect twice.
Assuming conventional treatment reduces PFAS. Coagulation, sedimentation, filtration, and disinfection have essentially no effect on these compounds, so finished water concentrations generally track source water concentrations unless dedicated PFAS treatment has been installed. Related and equally consequential: conventional advanced oxidation is not PFAS treatment either, and can raise measured PFOA and PFOS by converting precursors into terminal compounds. A utility planning on either assumption is planning on a reduction that will not appear in the data.
PFAS in U.S. drinking water is governed by the National Primary Drinking Water Regulation finalized in 2024 under Safe Drinking Water Act authority, administered by EPA and state primacy agencies, with many states operating their own standards alongside it. Nationwide occurrence data for regulated systems derives from the fifth Unregulated Contaminant Monitoring Rule. Analysis follows EPA Method 537.1 or 533 for drinking water and EPA Method 1633 for wastewater, biosolids, soil, sediment, and tissue; the methods differ in compound coverage and are not interchangeable across matrices. PFOA and PFOS are designated hazardous substances under CERCLA. Point-of-use and point-of-entry devices are certified to NSF/ANSI 53 and NSF/ANSI 58 for PFOA and PFOS reduction, and materials in contact with potable water must comply with NSF/ANSI/CAN 61 and NSF/ANSI 372. In the European Union, individual compounds are restricted under the Persistent Organic Pollutants Regulation, a universal PFAS restriction proposal is under evaluation through REACH, and the Drinking Water Directive sets parametric values. Because this landscape continues to change and remains subject to litigation, verify current requirements with the relevant agency before relying on them.
Analytical method differs by matrix and determines which compounds are reported. Reporting limit determines what a non-detect means and must be specified relative to the applicable standard. Compound list matters because a system can meet a PFOA limit while failing on a short-chain compound. System classification determines which obligations apply and whether any apply at all. Sampling protocol carries more weight than in almost any other contaminant programme because of cross-contamination risk. And source water type governs how much variability to expect and therefore how many samples characterization actually requires.
Not on its own. A detection means the compound was present above the laboratory’s reporting limit, which may be far below any regulatory standard. What matters is the concentration relative to the applicable limit — the federal MCLs of 4.0 parts per trillion for PFOA and PFOS and 10 parts per trillion for several others, or a state standard where one is more stringent. Read the result, the reporting limit, and the limit together.
No. The Safe Drinking Water Act applies to public water systems, and private domestic wells fall outside it entirely — no required monitoring, no MCL, no notification. Testing is voluntary and paid for by the household. Since private wells are common in exactly the rural areas near airfields, fire training grounds, landfills, and biosolids application sites where PFAS concentrates, well owners near any of those should consider testing regardless of the absence of an obligation.
Almost certainly not, unless treatment was installed specifically for it. Coagulation, sedimentation, filtration, and disinfection have essentially no effect on PFAS, so finished water concentrations generally match source water concentrations. Removal requires granular activated carbon, ion exchange, or membrane treatment installed for that purpose.
A health advisory is non-enforceable guidance indicating a concentration below which adverse effects are not anticipated. A maximum contaminant level is an enforceable standard: exceeding it is a violation with defined monitoring, notification, and corrective action consequences. EPA’s 2022 interim health advisories for PFOA and PFOS were guidance; the 2024 MCLs are regulation.
Because the percentage depends almost entirely on the reporting limit, the compound list, and the population sampled. A study using a very low reporting limit across many compounds will report detections in a large share of samples; the same water assessed against a higher limit and a shorter list will show far fewer. Always cite the dataset, the reporting limit, and the compound list alongside any occurrence figure.
More than once, and across conditions. Groundwater is comparatively stable in the short term, so fewer samples may characterize it adequately, though plumes shift over years. Surface water varies substantially with flow and season, and concentrations typically peak at low flow, so sampling only during normal conditions can miss the exceedance entirely. Confirmatory resampling before acting on any result is standard practice.
Despite regulatory advancements, public awareness around PFAS remains low. Communities often lack the infrastructure to effectively test and treat PFAS contaminants, particularly in rural areas.
States and municipalities face significant financial burdens for upgrading treatment facilities and managing PFAS contamination. Funding sources, such as the Infrastructure Investment and Jobs Act, provide a mechanism for support but often remain inadequate.
The distribution of the burden deserves emphasis. Small community systems face the same maximum contaminant levels as large utilities while serving a fraction of the ratepayers to fund compliance, and they typically lack in-house engineering capacity to evaluate options. The available responses — state assistance programmes, regional consolidation, shared operations, and interconnection with larger neighbours — are as much institutional as technical, and for many small systems the institutional path will determine the outcome more than the treatment technology does.
As we move through 2025, the presence of PFAS in water is a challenge that demands urgent attention. Continued regulatory evolution, combined with innovative treatment technologies, provides a roadmap for addressing this public health crisis. By investing in comprehensive treatment solutions and enhancing public awareness, we can mitigate the risks associated with PFAS and safeguard our water resources for future generations.
Reduced to a sequence, the response to occurrence runs: confirm the result before acting, characterize the source compound by compound and across seasons, locate contributors where source control is possible, evaluate non-treatment options before capital, plan treatment around the residual as much as the water, and communicate early in plain terms. In that order, the response follows from the evidence rather than from the alarm.
Are you a municipal director or an environmental engineer? If you’re concerned about PFAS in your water supply, contact our team today for a comprehensive consultation on the latest treatment technologies and regulatory compliance strategies. Let us help you protect public health and the environment.